Prevalence of norovirus GII-4 antibodies in Finnish children

Journal of Medical Virology

Volumn 83, Issue 3, 2011, Pages 525-531

  Nurminen, K ^a   Blazevic, V ^a   Huhti, L ^a   RaSaNen, S ^a,b   Koho, T ^c   HytoNen, V P ^c   Vesikari, T ^a,b  

^a UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Antibody avidity; Antibody responses; Blocking antibodies; ELISA; NoV

Indexed keywords

CARBOHYDRATE ANTIGEN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ACUTE GASTROENTERITIS; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BACULOVIRUS; BINDING AFFINITY; CHILD; CORRELATION ANALYSIS; CROSS REACTION; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FINLAND; GENOTYPE; GROUPS BY AGE; HUMAN; INFANT; INSECT CELL; NONHUMAN; NOROVIRUS; NOROVIRUS GII 2; NOROVIRUS GII 4; PEDIATRICS; PRESCHOOL CHILD; PRIMARY INFECTION; RECURRENT INFECTION; SEROPREVALENCE; VIRAL GASTROENTERITIS; VIRUS LIKE AGENT;

ACUTE DISEASE; ADOLESCENT; AGE FACTORS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; CALICIVIRIDAE INFECTIONS; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; FINLAND; GASTROENTERITIS; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; NOROVIRUS; PREVALENCE; SEROEPIDEMIOLOGIC STUDIES;

HEXAPODA; NOROVIRUS; ROTAVIRUS;

EID: 78851468717     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21990     Document Type: Article

References (38)

1. Belliot G, Noel JS, Li JF, Seto Y, Humphrey CD, Ando T, Glass RI, Monroe SS. 2001. Characterization of capsid genes, expressed in the baculovirus system, of three new genetically distinct strains of "Norwalk-like viruses". J Clin Microbiol 39: 4288-4295.
2. Cannon JL, Lindesmith LC, Donaldson EF, Saxe L, Baric RS, Vinje J. 2009. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol 83: 5363-5374.
3. Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, Estes MK. 2004. Laboratory efforts to cultivate noroviruses. J Gen Virol 85: 79-87.
4. Farkas T, Thornton SA, Wilton N, Zhong W, Altaye M, Jiang X. 2003. Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. J Infect Dis 187: 187-193.
5. Farkas T, Deng X, Ruiz-Palacios G, Morrow A, Jiang X. 2006. Development of an enzyme immunoassay for detection of sapovirus-specific antibodies and its application in a study of seroprevalence in children. J Clin Microbiol 44: 3674-3679.
6. Gallimore CI, Iturriza-Gomara M, Xerry J, Adigwe J, Gray JJ. 2007. Inter-seasonal diversity of norovirus genotypes: Emergence and selection of virus variants. Arch Virol 152: 1295-1303.
7. Gray JJ, Jiang X, Morgan-Capner P, Desselberger U, Estes MK. 1993. Prevalence of antibodies to Norwalk virus in England: Detection by enzyme-linked immunosorbent assay using baculovirus-expressed Norwalk virus capsid antigen. J Clin Microbiol 31: 1022-1025.
8. Gray JJ, Cunliffe C, Ball J, Graham DY, Desselberger U, Estes MK. 1994. Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus. J Clin Microbiol 32: 3059-3063.
9. Green KY. 2007. Caliciviridae: The noroviruses. In: Fields BN, editor. Fields virology. 5 edition. Philadelphia, PA: Lippincott Williams & Wilkins. pp 949-980.
10. Gutierrez J, Maroto C. 1996. Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. Microbios 87: 113-121.
11. Harrington PR, Lindesmith L, Yount B, Moe CL, Baric RS. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J Virol 76: 12335-12343.
12. Iritani N, Seto T, Hattori H, Natori K, Takeda N, Kubo H, Yamano T, Ayata M, Ogura H, Seto Y. 2007. Humoral immune responses against norovirus infections of children. J Med Virol 79: 1187-1193.
13. Jiang X, Wang M, Graham DY, Estes MK. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol 66: 6527-6532.
14. Jiang X, Wilton N, Zhong WM, Farkas T, Huang PW, Barrett E, Guerrero M, Ruiz-Palacios G, Green KY, Green J, Hale AD, Estes MK, Pickering LK, Matson DO. 2000b. Diagnosis of human caliciviruses by use of enzyme immunoassays. J Infect Dis 181: S349-S359.
15. Jing Y, Qian Y, Huo Y, Wang LP, Jiang X. 2000a. Seroprevalence against Norwalk-like human caliciviruses in Beijing, China. J Med Virol 60: 97-101.
16. Kanno A, Kazuyama Y. 2002. Immunoglobulin G antibody avidity assay for serodiagnosis of hepatitis C virus infection. J Med Virol 68: 229-233.
17. Kobayashi S, Fujiwara N, Takeda N, Minagawa H. 2009. Seroepidemiological study of norovirus infection in Aichi Prefecture, Japan. Microbiol Immunol 53: 356-359.
18. Lew JF, Valdesuso J, Vesikari T, Kapikian AZ, Jiang X, Estes MK, Green KY. 1994. Detection of Norwalk virus or Norwalk-like virus infections in Finnish infants and young children. J Infect Dis 169: 1364-1367.
19. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, Stewart P, LePendu J, Baric R. 2003. Human susceptibility and resistance to Norwalk virus infection. Nat Med 9: 548-553.
20. Lindesmith LC, Donaldson E, Leon J, Moe CL, Frelinger JA, Johnston RE, Weber DJ, Baric RS. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J Virol 84: 1800-1815.
21. LoBue AD, Lindesmith L, Yount B, Harrington PR, Thompson JM, Johnston RE, Moe CL, Baric RS. 2006. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24: 5220-5234.
22. Matsui SM, Greenberg HB. 2000. Immunity to calicivirus infection. J Infect Dis 181: S331-S335.
23. Maunula L, Von Bonsdorff CH. 2005. Norovirus genotypes causing gastroenteritis outbreaks in Finland 1998-2002. J Clin Virol 34: 186-194.
24. Moreno-Espinosa S, Farkas T, Jiang X. 2004. Human caliciviruses and pediatric gastroenteritis. Semin Pediatr Infect Dis 15: 237-245.
25. Murphy K, Travers P, Walport M. 2008. The adaptive immune response. In: Masson S, Lawrence E, Lucas G, Goatly B, editors. Janeway's immunobiology. 7th edition. New York, NY, USA and Abingdon, UK: Garland Science. pp 323-490.
26. Nakata S, Honma S, Numata K, Kogawa K, Ukae S, Adachi N, Jiang X, Estes MK, Gatheru Z, Tukei PM, Chiba S. 1998. Prevalence of human calicivirus infections in Kenya as determined by enzyme immunoassays for three genogroups of the virus. J Clin Microbiol 36: 3160-3163.
27. Nicollier-Jamot B, Pico V, Pothier P, Kohli E. 2003. Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J Clin Microbiol 41: 3901-3904.
28. Numata K, Nakata S, Jiang X, Estes MK, Chiba S. 1994. Epidemiological study of Norwalk virus infections in Japan and Southeast Asia by enzyme-linked immunosorbent assays with Norwalk virus capsid protein produced by the baculovirus expression system. J Clin Microbiol 32: 121-126.
29. Pang XL, Joensuu J, Vesikari T. 1999. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 18: 420-426.
30. Pelosi E, Lambden PR, Caul EO, Liu B, Dingle K, Deng Y, Clarke IN. 1999. The seroepidemiology of genogroup 1 and genogroup 2 Norwalk-like viruses in Italy. J Med Virol 58: 93-99.
31. Rasanen S, Lappalainen S, Kaikkonen S, Hamalainen M, Salminen M, Vesikari T. 2010. Mixed viral infections causing acute gastroenteritis in children in a waterborne outbreak. Epidemiol Infect 22: 1-8.
32. Rockx B, Baric RS, de Grijs I, Duizer E, Koopmans MP. 2005. Characterization of the homo- and heterotypic immune responses after natural norovirus infection. J Med Virol 77: 439-446.
33. Ryder RW, Singh N, Reeves WC, Kapikian AZ, Greenberg HB, Sack RB. 1985. Evidence of immunity induced by naturally acquired rotavirus and Norwalk virus infection on two remote Panamanian islands. J Infect Dis 151: 99-105.
34. Siebenga JJ, Vennema H, Zheng DP, Vinje J, Lee BE, Pang XL, Ho EC, Lim W, Choudekar A, Broor S, Halperin T, Rasool NB, Hewitt J, Greening GE, Jin M, Duan ZJ, Lucero Y, O'Ryan M, Hoehne M, Schreier E, Ratcliff RM, White PA, Iritani N, Reuter G, Koopmans M. 2009. Norovirus illness is a global problem: Emergence and spread of norovirus GII.4 variants, 2001-2007. J Infect Dis 200: 802-812.
35. Talal AH, Moe CL, Lima AA, Weigle KA, Barrett L, Bangdiwala SI, Estes MK, Guerrant RL. 2000. Seroprevalence and seroincidence of Norwalk-like virus infection among Brazilian infants and children. J Med Virol 61: 117-124.
36. Treanor JJ, Jiang X, Madore HP, Estes MK. 1993. Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus. J Clin Microbiol 31: 1630-1634.
37. Zeng SQ, Halkosalo A, Salminen M, Szakal ED, Karvonen A, Vesikari T. 2010. Norovirus gastroenteritis in young children receiving human rotavirus vaccine. Scand J Infect Dis 42: 540-544.
38. Zheng D, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. 2006. Norovirus classification and proposed strain nomenclature. Virology 346: 312-323.